Intest Res.  2025 Jan;23(1):3-5. 10.5217/ir.2024.00204.

Elucidating the association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a focus on systemic inflammation

• Kim S
• Im JP

• KMID: 2564391
• DOI: http://doi.org/10.5217/ir.2024.00204

Reference

1. Nagata T, Funakoshi S, Morihara D, et al. Malnutrition and inflammation status in nonobese patients with inflammatory bowel disease are associated with nonalcoholic fatty liver disease: a retrospective study. Intest Res. 2023; 21:471–480.

2. Aggarwal K, Singh B, Goel A, et al. Complex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities. Intest Res. 2024; 22:414–427.

3. Boustany A, Rahhal R, Mitri J, et al. The impact of nonalcoholic fatty liver disease on inflammatory bowel disease-related hospitalization outcomes: a systematic review. Eur J Gastroenterol Hepatol. 2023; 35:1067–1074.

4. Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med. 2024; 19:275–293.

5. Wang YH, Chung CH, Huang TY, et al. Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study. Intest Res. 2025; 23:76–84.